2016
DOI: 10.15252/embr.201540505
|View full text |Cite
|
Sign up to set email alerts
|

NAT 10 regulates p53 activation through acetylating p53 at K120 and ubiquitinating Mdm2

Abstract: As a genome guardian, p53 maintains genome stability by arresting cells for damage repair or inducing cell apoptosis to eliminate the damaged cells in stress response. Several nucleolar proteins stabilize p53 by interfering Mdm2-p53 interaction upon cellular stress, while other mechanisms by which nucleolar proteins activate p53 remain to be determined. Here, we identify NAT10 as a novel regulator for p53 activation. NAT10 acetylates p53 at K120 and stabilizes p53 by counteracting Mdm2 action. In addition, NAT… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

3
132
1

Year Published

2016
2016
2024
2024

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 126 publications
(136 citation statements)
references
References 59 publications
3
132
1
Order By: Relevance
“…In patients 309, 310, and 401, mutations from known cancer/MMR drivers were observed in the shared ancestral VAF cluster, including NRAS p.Gln61Arg from 309, BRAF p.Val600Glu from 310, and POLG p.Trp688fs from 401. In patients 312 and 403, although no variants from known cancer genes were found, we did identify rare shared damaging variants in cancer‐related genes NAT10 (a p53 regulator) from patient 312 and ALDH2 (protective to DNA damage) from patient 403. Key cancer‐related mutations seemed to occur as the origin for both ATCs and WDTC.…”
Section: Resultsmentioning
confidence: 76%
“…In patients 309, 310, and 401, mutations from known cancer/MMR drivers were observed in the shared ancestral VAF cluster, including NRAS p.Gln61Arg from 309, BRAF p.Val600Glu from 310, and POLG p.Trp688fs from 401. In patients 312 and 403, although no variants from known cancer genes were found, we did identify rare shared damaging variants in cancer‐related genes NAT10 (a p53 regulator) from patient 312 and ALDH2 (protective to DNA damage) from patient 403. Key cancer‐related mutations seemed to occur as the origin for both ATCs and WDTC.…”
Section: Resultsmentioning
confidence: 76%
“…Of note, NAT10 was previously described as a protein acetyltransferase with demonstrated activities against α-tubulin, histones and p53 (Larrieu et al, 2014; Liu et al, 2016; Lv et al, 2003; Shen et al, 2009). In contrast to the dramatic reduction observed in ac4C levels, immunoblotting with acetyl-specific antibodies showed little change in protein acetylation in NAT10−/− as compared to wildtype HeLa cells (Figure S1J).…”
Section: Resultsmentioning
confidence: 99%
“…Recently, NAT10 was described as a protein regulating p53 activation through its acetylation and also that NAT10 was upregulated under stress conditions in a p53-dependent manner. Thus, NAT10 forms a positive regulation feedback with p53 in response to stress [84]. …”
Section: Discussionmentioning
confidence: 99%